Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
It’s the first PCR-based sexually transmitted infection test platform for at-home use
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
The PCR-driven test provides results in about 20 minutes in non-laboratory settings
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab